What guidance, if any, did the company provide for Q3 2025 and the full‑year 2025 outlook?

Guidance Summary:

The press release announcing FinVolution’s upcoming Q2 2025 earnings release does not contain any forward‑looking guidance for Q3 2025 or for the full‑year 2025. The company merely disclosed the date and time of its earnings call (August 20, 2025, 8:30 p.m. ET) and did not provide revenue, earnings‑per‑share, or margin forecasts for the next quarter or the year‑end. Consequently, investors currently have no company‑specific quantitative expectations to anchor the stock’s valuation for the remainder of 2025.

Trading Implications:

In the absence of formal guidance, the market will largely price the upcoming Q2 results and any “soft‑spoken” commentary from management. Traders should monitor the earnings call for qualitative cues—such as comments on client acquisition trends, product‑rollout timelines, or macro‑risk exposure—that could serve as implicit forward guidance. If management signals strong pipeline momentum or cost‑control improvements, the stock may rally on a “positive surprise” narrative despite the lack of explicit numbers. Conversely, any mention of slower growth or heightened regulatory risk could trigger downside pressure, especially given the current neutral‑to‑bull technical setup (the stock is holding above its 50‑day moving average and approaching a key resistance near $42.50).

Actionable Steps:

1. Pre‑earnings: Position short‑term trades around the earnings release; consider a “buy‑the‑rumor” approach if the stock has rallied on expectations of a beat, but set tight stop‑losses near the 50‑day EMA to guard against a potential miss.

2. Post‑earnings: If management provides qualitative optimism for Q3 and the full year, consider adding to a bullish position with a target near the next resistance level (≈$45) and a trailing stop to protect gains. If the commentary is muted or negative, consider exiting or shorting to test the next support (~$38) as the lack of guidance may exacerbate downside momentum.

Bottom line: The current lack of explicit Q3/2025 outlook leaves the market’s expectations open‑ended, making the upcoming earnings call the pivotal catalyst for price direction. Use technical levels for risk management and focus on management’s narrative for any implicit guidance.